Cargando…

Low Levels of Adenosine and GDNF Are Potential Risk Factors for Parkinson’s Disease with Sleep Disorders

Sleep disturbances are the most prevalent non-motor symptoms in the preclinical stage of Parkinson’s disease (PD). Adenosine, glial-derived neurotrophic factor (GDNF), and associated neurotransmitters are crucial in the control of sleep arousal. This study aimed to detect the serum levels of adenosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Li, Gao, Zheng, Chen, Gang, Geng, Deqin, Gao, Dianshuai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953846/ https://www.ncbi.nlm.nih.gov/pubmed/36831743 http://dx.doi.org/10.3390/brainsci13020200

Ejemplares similares

Mechanism of methylation and acetylation of high GDNF transcription in glioma cells: A review
por: Zhang, Lin, et al.
Publicado: (2019)

Crosstalk between DNA methylation and histone acetylation triggers GDNF high transcription in glioblastoma cells
por: Zhang, Baole, et al.
Publicado: (2020)

The Future of GDNF in Parkinson's Disease
por: Manfredsson, Fredric P., et al.
Publicado: (2020)

Lower GDNF Serum Level Is a Possible Risk Factor for Constipation in Patients With Parkinson Disease: A Case–Control Study
por: Chen, Gang, et al.
Publicado: (2022)

Serum glial cell line-derived neurotrophic factor (GDNF) a potential biomarker of executive function in Parkinson’s disease
por: Tong, Shu-Yan, et al.
Publicado: (2023)

Failure of Glial Cell-Line Derived Neurotrophic Factor (GDNF) in Clinical Trials Orchestrated By Reduced NR4A2 (NURR1) Transcription Factor in Parkinson’s Disease. A Systematic Review
por: Kambey, Piniel Alphayo, et al.
Publicado: (2021)

N-cadherin-ERα-Src signal models mediate the synergistic potentiation of activation of PI3K/Akt signal pathway in injured dopaminergic neurons by GDNF and E2
por: Shi, Zixiao, et al.
Publicado: (2012)

The Actin Cytoskeleton Is Involved in Glial Cell Line-Derived Neurotrophic Factor (GDNF)-Induced Ret Translocation into Lipid Rafts in Dopaminergic Neuronal Cells
por: Li, Li, et al.
Publicado: (2017)

GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson’s disease
por: d’Anglemont de Tassigny, Xavier, et al.
Publicado: (2015)

Combination therapy using GDNF and cell transplant in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Pre-α-pro-GDNF and Pre-β-pro-GDNF Isoforms Are Neuroprotective in the 6-hydroxydopamine Rat Model of Parkinson's Disease
por: Penttinen, Anna-Maija, et al.
Publicado: (2018)

Blunt dopamine transmission due to decreased GDNF in the PFC evokes cognitive impairment in Parkinson’s disease
por: Tang, Chuan-Xi, et al.
Publicado: (2022)

Testosterone upregulates glial cell line-derived neurotrophic factor (GDNF) and promotes neuroinflammation to enhance glioma cell survival and proliferation
por: Kanwore, Kouminin, et al.
Publicado: (2023)

Improving therapeutic potential of GDNF family ligands
por: Runeberg-Roos, Pia, et al.
Publicado: (2020)

Sleeping Beauty transposon system for GDNF overexpression of entrapped stem cells in fibrin hydrogel in a rat model of Parkinson’s disease
por: Stahn, Laura, et al.
Publicado: (2023)

Continuous theta-burst stimulation enhances and sustains neurogenesis following ischemic stroke
por: Zong, Xuemei, et al.
Publicado: (2022)

Blueberry juice augments exercise-induced neuroprotection in a Parkinson’s disease model through modulation of GDNF levels
por: Castro, Sandra L., et al.
Publicado: (2022)

Using Extracellular Vesicles Released by GDNF-Transfected Macrophages for Therapy of Parkinson Disease
por: Zhao, Yuling, et al.
Publicado: (2022)

Ultrasound-Triggered Effects of the Microbubbles Coupled to GDNF Plasmid-Loaded PEGylated Liposomes in a Rat Model of Parkinson's Disease
por: Yue, Peijian, et al.
Publicado: (2018)

Adenosine and Sleep
por: Bjorness, Theresa E, et al.
Publicado: (2009)

GDNF-Transfected Macrophages Produce Potent Neuroprotective Effects in Parkinson's Disease Mouse Model
por: Zhao, Yuling, et al.
Publicado: (2014)

Stress-Induced Executive Dysfunction in GDNF-Deficient Mice, A Mouse Model of Parkinsonism
por: Buhusi, Mona, et al.
Publicado: (2016)

GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop
por: Barker, Roger A., et al.
Publicado: (2020)

Role of calbindin-D28K in estrogen treatment for Parkinson's disease★
por: Wang, Chunhua, et al.
Publicado: (2013)

Comparative Analysis of the Effects of Neurotrophic Factors CDNF and GDNF in a Nonhuman Primate Model of Parkinson’s Disease
por: Garea-Rodríguez, Enrique, et al.
Publicado: (2016)

Small-Molecule Ligands as Potential GDNF Family Receptor Agonists
por: Ivanova, Larisa, et al.
Publicado: (2018)

GDNF and the RET Receptor in Cancer: New Insights and Therapeutic Potential
por: Mulligan, Lois M.
Publicado: (2019)

Photoreceptor preservation induced by intravitreal controlled delivery of GDNF and GDNF/melatonin in rhodopsin knockout mice
por: García-Caballero, Cristina, et al.
Publicado: (2018)

GDNF Promotes Survival and Therapeutic Efficacy of Human Adipose-Derived Mesenchymal Stem Cells in a Mouse Model of Parkinson’s Disease
por: Sun, Shoujia, et al.
Publicado: (2020)

Noninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson’s Disease
por: Fan, Ching-Hsiang, et al.
Publicado: (2016)

Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse model
por: Drinkut, Anja, et al.
Publicado: (2016)

GDNF Receptor Agonist Alleviates Motor Imbalance in Unilateral 6-Hydroxydopamine Model of Parkinson’s Disease
por: Renko, Juho-Matti, et al.
Publicado: (2020)

Non-toxic HSC Transplantation-Based Macrophage/Microglia-Mediated GDNF Delivery for Parkinson’s Disease
por: Chen, Cang, et al.
Publicado: (2019)

Finding an Optimal Level of GDNF Overexpression: Insights from Dopamine Cycling
por: Marshall, Pepin
Publicado: (2023)

Sleep Disturbance as Potential Risk and Progression Factor for Parkinson’s Disease
por: Bohnen, Nicolaas I., et al.
Publicado: (2019)

Increased Physiological GDNF Levels Have No Effect on Dopamine Neuron Protection and Restoration in a Proteasome Inhibition Mouse Model of Parkinson’s Disease
por: Olfat, Soophie, et al.
Publicado: (2023)

The GDNF Family: A Role in Cancer?
por: Fielder, Graeme C., et al.
Publicado: (2017)

TGF-β1 Increases GDNF Production by Upregulating the Expression of GDNF and Furin in Human Granulosa-Lutein Cells
por: Yin, Jingwen, et al.
Publicado: (2020)

Correction to: Ret is essential to mediate GDNF’s neuroprotective and neuroregenerative effect in a Parkinson disease mouse model
por: Drinkut, Anja, et al.
Publicado: (2018)

Adenosine, Energy Metabolism, and Sleep
por: Porkka-Heiskanen, Tarja, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_tvuurkcet0qt1vbnllnfkufhci